Industry Spotlight
Merck invests $25 million in a Kansas cell culture media plant, aiming to meet rising demand for advanced therapeutics while aligning with sustainability goals.
Edited by Ben Norris |
06 December 2023
Cell & Gene Therapy Manufacturing